Vicora offers treatment of numerous vascular illnesses, including pulmonary embolism, deep vein thrombosis.
Vicora has raised $2.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2026.
Vicora's investors include S2 Ventures Partners, Egret Healthcare Ventures.
Vicora is headquartered in Buffalo, United States.
Vicora offers treatment of numerous vascular illnesses, including pulmonary embolism, deep vein thrombosis.
Vicora is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vicora — Funding & Investors." VCBacked, September 18, 2026, https://www.vcbacked.co/company/vicora. Accessed October 1, 2026.
VCBacked. (2026). Vicora — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/vicora
{{cite web |title=Vicora — Funding & Investors |url=https://www.vcbacked.co/company/vicora |website=VCBacked |access-date=October 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated